Yew Bio-Pharm Group, Inc.
YEWB · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $1 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $8 | $0 | $32 |
| Inventory | $0 | $3 | $6 | $3 |
| Other Curr. Assets | $9 | $1 | $6 | $0 |
| Total Curr. Assets | $10 | $12 | $12 | $35 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $42 | $40 | $35 | $6 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $2 | $2 | $11 |
| Total NC Assets | $48 | $43 | $37 | $17 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $58 | $54 | $50 | $53 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $9 | $9 | $6 | $6 |
| Tax Payable | $1 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $2 | $1 | $0 |
| Total Curr. Liab. | $11 | $10 | $7 | $7 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $1 | $1 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $0 |
| Total NC Liab. | $2 | $2 | $2 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $13 | $13 | $9 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $31 | $30 | $29 | $30 |
| AOCI | $1 | -$2 | $2 | $4 |
| Other Equity | $13 | $14 | $14 | $14 |
| Total Equity | $45 | $41 | $41 | $45 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $58 | $54 | $50 | $53 |
| Net Debt | $9 | $8 | $5 | $5 |